OMER Form 4: Thomas Bumol receives annual 15k stock option award
Rhea-AI Filing Summary
On June 27, 2025, Omeros Corporation (ticker: OMER) granted non-employee director Thomas F. Bumol a stock option for 15,000 common shares at an exercise price of $3.20 per share, as disclosed in this Form 4 filed on July 1, 2025. The award is part of the company’s recurring director compensation program, automatically issued at each annual shareholder meeting to directors who have served at least six months and will continue to serve. The option vests in full on the day prior to the 2026 annual meeting, contingent upon Bumol’s continued board service. Following the grant, Bumol beneficially owns 15,000 derivative securities (options) with direct ownership. No shares of common stock were bought or sold, and no cash consideration changed hands.
The filing is a standard, non-cash compensation event and does not involve open-market transactions, changes in beneficial ownership of outstanding common shares, or the adoption of a Rule 10b5-1 trading plan. As such, it is considered routine in nature and is unlikely to have a material impact on Omeros’s valuation or trading dynamics.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine director option grant; no immediate valuation impact.
The 15,000-share option award to Director Bumol mirrors Omeros’s established non-employee director compensation policy and represents less than 0.03% of the company’s ~53 million outstanding shares. Because it is a non-cash, at-the-money grant with a one-year vesting cliff, the economic cost is limited to modest dilution if exercised. There is no indication of insider buying or selling of common shares, nor any signaling regarding future operational performance. Consequently, the disclosure is neutral for investors and does not alter the investment thesis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
Footnotes (1)
- Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 27, 2025. This option will fully vest and become exercisable on the day before the date of the 2026 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.
